Interchange Capital Partners, LLC Editas Medicine, Inc. Transaction History

Interchange Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $361,493 - $654,361	-11,553 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$39.71 - $90.58 $50,828 - $115,942	-1,280 Reduced 9.97%	11,553 $502,000
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $347,389 - $1.08 Million	12,833 New	12,833 $899,000

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Interchange Capital Partners, LLC with notifications on news.